RE:5% and 95% of dataNo confusion on my part. The point is, with all these undisclosed measurements how can it be stated that RVX-208 might not be warranted for cardiovascular disease? I'm not really buying that they don't have any figures on the unexpected strong placebo results. There has to be some data available in order to make that statement, or was that just twisting the knife? True, the IVUS results failed the primary endpoint but there are many other factors to consider as a potential treatment, alone or in combination with other drugs.